11 beta-hydroxysteroid dehydrogenase type 1 promotes differentiation of 3T3-L1 preadipocyte (Q40105005)

17 September 2017

title

11 beta-hydroxysteroid dehydrogenase type 1 promotes differentiation of 3T3-L1 preadipocyte (English)

1 reference

17 September 2017

1 reference

Yun Liu

1

1 reference

17 September 2017

Yan Sun

2

1 reference

17 September 2017

Ting Zhu

3

1 reference

17 September 2017

Yu Xie

4

1 reference

17 September 2017

Jing Yu

5

1 reference

17 September 2017

Wen-lan Sun

6

1 reference

17 September 2017

Guo-xian Ding

7

1 reference

17 September 2017

Gang Hu

8

1 reference

17 September 2017

publication date

1 August 2007

1 reference

Acta Pharmacologica Sinica

17 September 2017

published in

1 reference

17 September 2017

volume

28

1 reference

17 September 2017

issue

8

1 reference

17 September 2017

page(s)

1198-1204

1 reference

11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00602.X

11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00602.X

Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00602.X

A transgenic model of visceral obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00602.X

11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00602.X

Prereceptor regulation of glucocorticoid action by 11beta-hydroxysteroid dehydrogenase: a novel determinant of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00602.X

Inhibition of adipocyte differentiation by resistin-like molecule alpha. Biochemical characterization of its oligomeric nature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00602.X

11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00602.X

Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00602.X

Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00602.X

11beta-Hydroxysteroid dehydrogenase expression and glucocorticoid synthesis are directed by a molecular switch during osteoblast differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00602.X

10.1111/J.1745-7254.2007.00602.X

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

17 September 2017

1052268290

0 references

1 reference